NEW YORK, Nov. 8 – GPC Biotech of Munich said Thursday it had agreed to build a $120 million genomics research center for German chemicals and pharmaceuticals company Altana, which will use the new facility to advance two of its drug discovery programs.

Under the terms of the three agreements that make up the five-and-a-half-year deal, Altana has committed $120 million to the center, which it will own, over the duration of the alliance. The new center will be based in Waltham, Mass.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.